KRYS vs TWST: stock comparison and AI forecast
Krystal Biotech, Inc. (KRYS) and Twist Bioscience Corp (TWST) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
KRYS Krystal Biotech, Inc.
- Price
- $295.90 +3.1% · 6M
- Market Cap
- $9.04B
- P/E Ratio
- 41.5x
- Size
- mid-cap
- AI Forecast
TWST Twist Bioscience Corp
- Price
- $129.04 +129.6% · 6M
- Market Cap
- $8.80B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- KRYS and TWST have similar market capitalizations ($9.04B and $8.80B).
- Over the last six months TWST returned +129.6% and KRYS +3.1%.
- KRYS turns 47.9% of its revenue into net income, against -31.7% for TWST.
- TWST carries 0.51 times debt per unit of equity, against 0.10 times for KRYS.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | KRYS | TWST |
|---|---|---|
| Market Cap | $9.04B | $8.80B |
| P/E Ratio | 41.45x | – |
| P/B Ratio | 6.30x | 19.74x |
| EPS | $7.36 | $-2.24 |
| Book Value/Share | $48.44 | $7.11 |
| Revenue/Share | $15.86 | $6.89 |
| FCF/Share | $10.46 | $-1.49 |
Profitability & Margins
| Metric | KRYS | TWST |
|---|---|---|
| ROE | 15.7% | -30.7% |
| ROA | 14.2% | -20.3% |
| ROIC | 15.8% | -26.3% |
| Gross Margin | – | 52.0% |
| Operating Margin | 48.4% | -33.6% |
| Net Margin | 47.9% | -31.7% |
| EBT Margin | 55.1% | -31.5% |
| Tax Rate | 13.0% | -0.6% |
Financial Health
| Metric | KRYS | TWST |
|---|---|---|
| Current Ratio | 7.89x | 2.67x |
| Quick Ratio | 7.53x | 2.38x |
| D/E Ratio | 0.10x | 0.51x |
| Financial Leverage | 1.10x | 1.51x |
| Interest Coverage | – | -2274.8x |
| Working Capital | $980M | $201M |
Cash Flow
| Metric | KRYS | TWST |
|---|---|---|
| Operating Cash Flow | $324M | -$53M |
| Free Cash Flow | $310M | -$93M |
| Capital Spending | -$14M | -$40M |
| OCF Growth YoY | 83.8% | – |
| FCF Growth YoY | 87.3% | – |
| FCF/Sales | 66.0% | -21.6% |
| CapEx/Sales | 3.0% | 9.3% |
Operational Efficiency
| Metric | KRYS | TWST |
|---|---|---|
| Asset Turnover | 0.30x | 0.64x |
| Receivables Turnover | 3.5x | 6.6x |
| Inventory Turnover | – | 5.9x |
| Fixed Assets Turnover | 3.1x | 3.9x |
| Days Sales Outstanding | 103 days | 55 days |
| Days Inventory | – | 62 days |
| Payables Period | – | 30 days |
| Cash Conversion Cycle | – | 87 days |
Income Statement
| Metric | KRYS | TWST |
|---|---|---|
| Total Revenue | $470M | $432M |
| Operating Income | $228M | -$145M |
| Net Income | $225M | -$137M |
| R&D Expense | $60M | $72M |
| SG&A Expense | $156M | $290M |
| Cost of Goods Sold | – | $207M |
Dividend & Shareholder Information
| Metric | KRYS | TWST |
|---|---|---|
| Shares Outstanding | 30M | 63M |
| Net Income Growth | 13.2% | – |
| EPS Growth | 1.7% | – |
KRYS vs TWST: stock comparison and AI forecast
Which is bigger, KRYS or TWST?
KRYS and TWST have similar market capitalizations ($9.04B and $8.80B).
Which stock performed better over the last six months, KRYS or TWST?
Over the last six months TWST returned +129.6% and KRYS +3.1%.
Which one does Intratio's AI model rank higher, KRYS or TWST?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.